Cancer types
Non-small cell lung cancer
Non-small cell lung cancer
Stage and molecular/PD-L1 results can change treatment options.
Sources checked · Introductory guide
On this page
Understanding the cancer
Includes adenocarcinoma and squamous cancers, distinct from small cell lung cancer.[1]
Before choosing treatment
Check histology, stage and treatment-related biomarkers such as EGFR.[1]
How treatment is planned
Options include surgery, radiation, chemotherapy, targeted therapy and immunotherapy.[1]
Questions for your care team
- Are all needed biomarker results available before choosing medicines?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.
Related entries
NGS testing
Cancer medicinesOsimertinib
Cancer medicinesPembrolizumab
Cancer typesSmall cell lung cancer
TestsCT scan
TestsBiopsy and pathology report
Cancer medicinesPemetrexed
Cancer medicinesAtezolizumab
Cancer medicinesDurvalumab
Cancer medicinesAlectinib
Cancer medicinesTrastuzumab deruxtecan
Genes & biomarkersKRAS variants
Genes & biomarkersEGFR variants
Genes & biomarkersALK fusions and rearrangements
Genes & biomarkersROS1 fusions
Genes & biomarkersBRAF variants
Genes & biomarkersHER2 / ERBB2 results
Genes & biomarkersRET fusions and variants
Genes & biomarkersMET exon 14 and amplification